Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Facial Plastic Surgeon Explains How Facelift Incisions Are Strategically Placed to Minimize Visible Scars
-
REELZ+ Direct-to-Consumer Streaming App Features All Live REELZ Programming Including "On Patrol: Live"
-
PMGC Holdings Announces Share Repurchases from Existing Shareholders
-
Pop Culture Group Co., Ltd Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
-
SolarBank Corporation Announces up to US$19 Million Equity Financing
-
4BY4 to Showcase AI Video Solution 'PIXELL' at NAB 2025 with 8K Association
-
Beko highlights preserving water could save up to hundreds in households bills, this World Water Day
-
OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category
-
Sow Good Reports Fourth Quarter 2024 Results
-
Dynamic Automotive Celebrates 30 Years of Service & Growth with Expansion
-
PRIVACY ALERT: Pennsylvania State Education Association Under Investigation for Data Breach of Over 500,000 Employee Records
-
DIAMONDROCK HOSPITALITY ANNOUNCES FIRST QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL
-
Shell invests in the Gato do Mato project in Brazil's pre-salt
-
HUGOTON ROYALTY TRUST DECLARES NO MARCH CASH DISTRIBUTION
-
CROSS TIMBERS ROYALTY TRUST DECLARES MARCH CASH DISTRIBUTION
-
PERMIAN BASIN ROYALTY TRUST ANNOUNCES MARCH CASH DISTRIBUTION AND EXCESS COST POSITION ON WADDELL RANCH PROPERTIES
-
King Copper Discovery Corp. Appoints Doug Kirwin Lead Strategic and Technical Advisor
-
Strategy Prices Perpetual Strife Preferred Stock Offering
-
Fresh Faces Rx Elevates Patient Care with Perfect Corp.’s AI-Powered Skincare Pro Technology
-
NV5 Acquires CRS Survey; Strengthens North Carolina Infrastructure Capabilities
-
iECURE Announces Presentation of Full Data for the First Infant Dosed with ECUR-506 in OTC-HOPE Phase 1/2 Clinical Trial at the 2025 ACMG Annual Clinical Genetics Meeting
-
Mira Reaches Major Milestone: 2.5M Users and 2B Daily Tokens Processed
-
Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update
-
Super League Sets Fourth Quarter and Full Year 2024 Earnings Date, March 28, 2025
-
AXIL Brands Sets Sights on Offline Expansion and Global Market Growth
-
Duolingo Announces the Grand Opening of Duo’s Treehouse
-
OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category
-
Pega Announces Quarterly Cash Dividend for Second Quarter of 2025
-
Vireo Growth Inc. Files Definitive Information Circular and Provides Merger Transaction Updates
-
Power Knot Launches LCD Biodigester for Cannabis Waste Management
-
New Final Bond Terms for the Danish Ship Finance A/S Base Prospectus dated 9 July 2024
-
Gundry MD Total Restore Achieves Over 7 Million Units Sold
-
Coca-Cola Europacific Partners plc Announces Annual Financial Report
-
Studio City International Holdings Limited Announces Filing of Annual Report on Form 20-F for Fiscal Year 2024
-
EPA Decision to Reevaluate Clean Air Permit for Atlantic Shores Offshore Wind Project Is a Big Win for Save LBI and New Jersey
-
Ucore Applauds White House Executive Action to Strengthen Critical Mineral Production
-
WhiteStar Communications Emerges to Address Zero Day; Adds James Massa as CRO
-
High-Quality Flooring at the Best Prices - Really Cheap Floors
-
Agape Care Group Named USA Today’s Top Workplace for 2nd Year
-
Director/PDMR Shareholding
-
Capital Media Group Awarded GSA Contract for Video, Audio, and Animation
-
CLOU's BESS Tour: Empowering Renewable Latin America
-
European Energy A/S: Minutes of Ordinary General Meeting
-
OS Therapies to Attend The Jones Healthcare and Technology Innovation Conference
-
Unico Connect Transforms Adult Education for 15,000+ Students with 'Highlands Brain' App
-
TCLE (01070.HK) Doubles Adjusted Profit attributable to Owners of the Parent YoY in 2024
-
Soligenix Announces Recent Accomplishments and Year End 2024 Financial Results
-
Almadex Files Memorial Documentation for Investment Arbitration Claim Against Mexico
-
Anteris Reports One-Year Patient Outcomes for DurAVR® THV
-
High Roller Reports Q4 and Full Year 2024 Results
